通腑疗法预防脑卒中相关性肺炎的临床研究

The Clinical Research of Relaxing Therapy's Prevention on Stroke Associated Pneumonia

目的:观察通腑疗法对脑卒中相关性肺炎的预防作用。方法:90例急性脑卒中患者随机分为通腑预防组和对照组;两组均给予常规西医治疗,通腑预防组在此基础上加用通腑疗法治疗,对比两组脑卒中相关性肺炎发生率,分析疗效;对两组治疗前后NIHSS评分、hs-CRP水平进行检测。结果:观察入组第21天对照组卒中相关性肺炎发生率为37.8%,通腑预防组为13.3%,经统计学分析有显著性差异(P=0.000<0.01);通腑预防组治疗后神经功能缺损评分(NIHSS评分)明显低于对照组(P=0.000<0.01),有显著性差异;通腑预防组治疗后hs-CRP水平明显低于对照组(P=0.002<0.01),有显著性差异。结论:急性脑卒中患者及早应用通腑疗法可以降低卒中相关性肺炎的发生率,促进神经功能的恢复,降低致残率,改善机体炎症反应。

Objective：Observing the preventive effects of relaxing therapy on stroke associated pneumonia.Methods：90 patients of acute stroke were divided into relaxing prevention group and comparison group randomly,45 cases of comparison group were treated by conventional western medicine,45 cases of relaxing prevention group were treated by conventional western medicine and relaxing therapy,observe the incidence of stroke associated pneumonia,analyzing the effection;observing NIHSS score and hs-CRP level of two groups before and after treatment.Results：21 days after treatment,the incidence of stroke associated pneumonia was 37.8% in the comparison group,the incidence of stroke associated pneumonia was 13.3% in the relaxing prevention group,through the statistical analysis（P = 0.000 〈0.01）,there was significant difference between two groups;the relaxing prevention group＇s NIHSS score was lower than the comparison group＇s significantly（P = 0.000 〈0.01）,there was significant difference between two groups;the relaxing prevention group＇s hs-CRP level was lower than the comparison group＇s significantly（P = 0.002 〈0.01）,there was significant difference between two groups.Conclusion：Early application of relaxing therapy on patients of acute stroke can reduce the incidence of stroke associated pneumonia,improve neurologic impairment,reduce morbidity and improve the body＇s inflammatory response.